RCKT ROCKET PHARMACEUTICALS INC Investments/Divestments 8-K Filing 2023 - Underwriting Agreement Rocket Pharmaceuticals, Inc. entered into an underwriting agreement to issue and sell shares of common stock and pre-funded warrants, with net proceeds expected to be approximately $188.9 million, primarily for the development of gene therapies and other corporate purposes.Get access to all SEC 8-K filings of the ROCKET PHARMACEUTICALS INC